Clinical Trial Site
Lübeck 23538
0 studies enrolling now · 3 studies all time
What they study most
ANCA-Associated Vasculitis, Atypical Hemolytic Uremic Syndrome, Atypical Hemolytic-Uremic Syndrome
Studies at this site
- Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
- A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
- Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment — Stopped early